Gene · 7067
Papers1,888
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,888
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mediator subunit MED1 differentially modulates mutant thyroid hormone receptor intracellular dynamics in Resistance to Thyroid Hormone syndrome. | Mol Cell Endocrinol | 2023 | 36191835 | PubTator, text mining | PubMed |
| Morphological and Functional Colonic Defects Caused by a Mutated Thyroid Hormone Receptor α. | Thyroid | 2023 | 36103385 | PubTator, text mining | PubMed |
| Nuclear receptors as potential therapeutic targets in peripheral arterial disease and related myopathy. | FEBS J | 2023 | 35942640 | PubTator, text mining | PubMed |
| Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells. | Autophagy | 2023 | 35435804 | PubTator, text mining | PubMed |
| Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer. | Endocr Oncol | 2022 | 37435460 | PubTator, text mining | PubMed |
| Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective. | Oncol Res | 2022 | 37305018 | PubTator, text mining | PubMed |
| Thyroid Hormones Enhance the Growth of Estrogen Receptor-Positive Breast Cancers. | Clin Thyroidol | 2022 | 36937987 | PubTator, text mining | PubMed |
| The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson's disease. | Front Cell Neurosci | 2022 | 36704248 | PubTator, text mining | PubMed |
| Advances and Emerging Therapies in the Treatment of Non-alcoholic Steatohepatitis. | touchREV Endocrinol | 2022 | 36694893 | PubTator, text mining | PubMed |
| Application of Single-Cell RNA Sequencing in Ovarian Development. | Biomolecules | 2022 | 36671432 | PubTator, text mining | PubMed |
| Computer-aided drug design combined network pharmacology to explore anti-SARS-CoV-2 or anti-inflammatory targets and mechanisms of Qingfei Paidu Decoction for COVID-19. | Front Immunol | 2022 | 36618410 | PubTator, text mining | PubMed |
| Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials. | Int J Mol Sci | 2022 | 36613602 | PubTator, text mining | PubMed |
| Population dynamics and antimicrobial resistance of Salmonella Derby ST40 from Shenzhen, China. | Front Microbiol | 2022 | 36605513 | PubTator, text mining | PubMed |
| Exploring the Potential Mechanism of Artemisinin and Its Derivatives in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking. | Comput Math Methods Med | 2022 | 36590764 | PubTator, text mining | PubMed |
| Molecular Cloning and Characterization of a Fasciola gigantica Nuclear Receptor Subfamily 1 (FgNR1). | Pathogens | 2022 | 36558792 | PubTator, text mining | PubMed |
| Ability of the Right Ventricle to Serve as a Systemic Ventricle in Response to the Volume Overload at the Neonatal Stage. | Biology (Basel) | 2022 | 36552341 | PubTator, text mining | PubMed |
| Upregulated ENC1 predicts unfavorable prognosis and correlates with immune infiltration in endometrial cancer. | Front Cell Dev Biol | 2022 | 36531950 | PubTator, text mining | PubMed |
| Integrating artificial intelligence into a talent management model to increase the work engagement and performance of enterprises. | Front Psychol | 2022 | 36506984 | PubTator, text mining | PubMed |
| Retrospective analysis and literature review of four cases of thyroid hormone resistance syndrome caused by THRB gene mutation. | Transl Pediatr | 2022 | 36506769 | PubTator, text mining | PubMed |
| Atrial Fibrillation with Heart Failure in a Case with Resistance to Thyroid Hormone Due to a Rare Thyroid Hormone Receptor β Gene Mutation. | Int J Mol Sci | 2022 | 36499571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7067/papers?page=12